Printer Friendly

LIFECORE REPORTS RESULTS OF ETHICON CLINICAL TRIAL

 LIFECORE REPORTS RESULTS OF ETHICON CLINICAL TRIAL
 CHASKA, Minn., Oct. 5 /PRNewswire/ -- Lifecore Biomedical, Inc.


(NASDAQ: LCBM) announced today that it had been informed by an official of the Ethicon, Inc., division of the Johnson and Johnson Company after the market close late Friday, Oct. 2, that partial statistical analysis of data resulting from Ethicon's ongoing anti-adhesion clinical trial with Lifecore's Tenalure(R) Brand sodium hyaluronate product was not demonstrating anticipated levels of efficacy.
 Lifecore indicated that the two companies were continuing to confer regarding the future direction of the ongoing clinical evaluation. Several options are available to the companies including further evaluation of the current hyaluronate product, bringing a second generation hyaluronate product to the clinic, or, discontinuing the project.
 Lifecore's President and CEO James W. Bracke, indicated that he was optimistic that the companies could continue to collaborate on this clinical project although the time frame for the project was "likely to be extended."
 Lifecore develops, manufactures and markets sterile medical devices for a variety of surgical applications, through both direct sales and OEM supplier relationships.
 -0- 10/5/92
 /CONTACT: James W. Bracke or John C. Heinmiller, 612-368-4300, both of Lifecore Biomedical/
 (LCBM) CO: Lifecore Biomedical, Inc. ST: Minnesota IN: MTC SU:


AL -- MN006 -- 6483 10/05/92 10:19 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 5, 1992
Words:214
Previous Article:SHAWMUT NATIONAL CORPORATION INTRODUCES BILL-LINE A TELEPHONE-BASED BILL-PAYING SERVICE
Next Article:CHECK PROCESSING LEAPS TO THE 21ST CENTURY: IBM TO DELIVER HPTS PROOF-OF-DEPOSIT IN DECEMBER
Topics:


Related Articles
LIFECORE BIOMEDICAL REPORTS THIRD QUARTER RESULTS
LIFECORE BIOMEDICAL REPORTS FISCAL 1992 RESULTS
LIFECORE BIOMEDICAL REPORTS FIRST QUARTER RESULTS; INCREASED ALCON ORDER
LIFECORE SIGNS LETTER OF INTENT REVISING ETHICON PRODUCT DEVELOPMENT RELATIONSHIP
LIFECORE ANNOUNCES PUBLIC STOCK OFFERING
LIFECORE TO SUPPLY MENTOR WITH OPHTHALMIC VISCOELASTIC SOLUTION
LIFECORE RECEIVES LUBRICOAT GEL PATENT NOTICE OF ALLOWANCE
Lifecore Reports Laparoscopic INTERGEL Solution Pilot Clinical Trial Results
Focal, Inc. Completes Enrollment in Pivotal U.S. Clinical Trial of FocalSeal-L Surgical Sealant
Focal, Inc. Reports First Quarter 1999 Results.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters